Ramsohoye P, Fritz I B
Department of Cellular Physiology, Babraham Institute, Cambridge, United Kingdom.
J Cell Physiol. 1995 Oct;165(1):145-54. doi: 10.1002/jcp.1041650117.
Carnitine and acylcarnitine derivatives have been reported to inhibit cell aggregation (Fritz and Burdzy, 1989, J. Cell. Physiol., 140:18-28). A follow-up of these observations showed that whereas the previously described effects of long-chain acylcarnitines were well replicated, those of carnitine on erythrocytes showed marked variability. The latter phenomenon was traced to the presence of silicates in carnitine solutions derived from the use of sodium hydroxide solutions stored in glass containers for the neutralization of carnitine. The present experiments have led to the discovery that oligomeric forms of silicates are powerful inhibitors of red blood cell aggregation which otherwise occurs in the presence of fibrinogen alone. The active form(s) of silicates in this assay, which appear to be generated by polymerization of silicates in metasilicate solutions on neutralization, are unstable and therefore transient under usual conditions. We estimate that the active oligomeric forms contain between 4 to 18 silicon atoms per molecule. When maintained at -18 degrees C in the presence of carnitine, but not in its absence, the active forms of oligomeric silicates remained stable for months, judging from their ability to inhibit cell aggregation. We conclude that carnitine stabilized the oligomeric form(s) of silicate, or that the species stabilized is an oligomeric silicate-carnitine complex. Comparable concentrations of choline, deoxycarnitine, or gamma-aminobutyrate were less effective in stabilizing the active silicate oligomers. The active forms of the silicate oligomers had Ki values of about 10 microM, calculated as the monomeric form, in inhibiting red blood cell aggregation. The data indicate that free carnitine does not directly inhibit erythrocyte inhibition, as previously interpreted, whereas long-chain acylcarnitine derivatives are active in the absence of silicates. Possible mechanism of actions of silicate oligomers on membranes are discussed.
据报道,肉碱和酰基肉碱衍生物可抑制细胞聚集(弗里茨和布尔齐,1989年,《细胞生理学杂志》,140:18 - 28)。对这些观察结果的后续研究表明,虽然先前描述的长链酰基肉碱的作用得到了很好的重现,但肉碱对红细胞的作用却表现出显著的变异性。后一种现象可追溯到用于中和肉碱的氢氧化钠溶液储存在玻璃容器中而导致肉碱溶液中存在硅酸盐。目前的实验发现,硅酸盐的低聚形式是红细胞聚集的强力抑制剂,而红细胞聚集在仅存在纤维蛋白原的情况下本来会发生。在该测定中,硅酸盐的活性形式似乎是在偏硅酸盐溶液中和时由硅酸盐聚合产生的,它们不稳定,因此在通常条件下是短暂的。我们估计活性低聚形式每分子含有4至18个硅原子。当在肉碱存在下保持在 - 18摄氏度时,从其抑制细胞聚集的能力判断,低聚硅酸盐的活性形式可稳定存在数月,而在无肉碱时则不然。我们得出结论,肉碱使硅酸盐的低聚形式稳定,或者说稳定的物种是低聚硅酸盐 - 肉碱复合物。胆碱、脱氧肉碱或γ - 氨基丁酸的可比浓度在稳定活性硅酸盐低聚物方面效果较差。硅酸盐低聚物的活性形式在抑制红细胞聚集方面,以单体形式计算的Ki值约为10微摩尔。数据表明,游离肉碱并不像先前解释的那样直接抑制红细胞聚集,而长链酰基肉碱衍生物在无硅酸盐时具有活性。文中讨论了硅酸盐低聚物对膜的可能作用机制。